-Bloomberg
AstraZeneca, European Commission Reach Settlement Agreement Over Vaccine Supply, Ending Litigation; AstraZeneca Commits to Deliver 60M by the End Q3 2021, 75M by the End of Q4 2021, 65M by the End of Q1 2022
AstraZeneca (NYSE: AZN) and the European Commission have reached an agreement that ends legal proceedings over the execution of the Advance Purchase Agreement for the delivery of the COVID-19 vaccine Vaxzevria (ChAdOx1-S [Recombinant]).